Invesco Ltd. Boosts Holdings in DENTSPLY SIRONA Inc. $XRAY

Invesco Ltd. lifted its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 31.2% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 523,317 shares of the medical instruments supplier’s stock after buying an additional 124,327 shares during the period. Invesco Ltd. owned approximately 0.26% of DENTSPLY SIRONA worth $7,818,000 at the end of the most recent quarter.

Other hedge funds have also recently modified their holdings of the company. Colonial Trust Co SC purchased a new position in shares of DENTSPLY SIRONA in the 4th quarter valued at $26,000. Mirae Asset Global Investments Co. Ltd. acquired a new stake in DENTSPLY SIRONA during the 1st quarter worth $25,000. True Wealth Design LLC boosted its stake in DENTSPLY SIRONA by 866.7% during the 4th quarter. True Wealth Design LLC now owns 2,175 shares of the medical instruments supplier’s stock worth $41,000 after purchasing an additional 1,950 shares during the period. Quarry LP boosted its stake in DENTSPLY SIRONA by 25.7% during the 4th quarter. Quarry LP now owns 3,816 shares of the medical instruments supplier’s stock worth $72,000 after purchasing an additional 780 shares during the period. Finally, Allworth Financial LP boosted its stake in DENTSPLY SIRONA by 175.8% during the 1st quarter. Allworth Financial LP now owns 3,949 shares of the medical instruments supplier’s stock worth $54,000 after purchasing an additional 2,517 shares during the period. 95.70% of the stock is owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Stock Down 1.8%

Shares of NASDAQ XRAY opened at $14.40 on Tuesday. The company has a quick ratio of 1.11, a current ratio of 1.69 and a debt-to-equity ratio of 1.13. DENTSPLY SIRONA Inc. has a 52 week low of $12.16 and a 52 week high of $27.48. The firm has a 50-day moving average price of $15.24 and a 200 day moving average price of $15.44. The stock has a market capitalization of $2.87 billion, a price-to-earnings ratio of -3.04, a price-to-earnings-growth ratio of 0.91 and a beta of 0.94.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $0.52 EPS for the quarter, beating the consensus estimate of $0.50 by $0.02. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. The firm had revenue of $936.00 million during the quarter, compared to analysts’ expectations of $929.67 million. During the same quarter last year, the business earned $0.49 earnings per share. The business’s revenue for the quarter was down 4.9% compared to the same quarter last year. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. Equities research analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 10th. Investors of record on Friday, September 26th will be paid a $0.16 dividend. The ex-dividend date is Friday, September 26th. This represents a $0.64 annualized dividend and a dividend yield of 4.4%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -13.50%.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the stock. Wells Fargo & Company decreased their price target on shares of DENTSPLY SIRONA from $16.00 to $15.00 and set an “equal weight” rating for the company in a research note on Friday, August 8th. Needham & Company LLC reiterated a “hold” rating on shares of DENTSPLY SIRONA in a research note on Monday, July 21st. Wall Street Zen cut shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Saturday, August 9th. Stifel Nicolaus decreased their price target on shares of DENTSPLY SIRONA from $19.00 to $17.00 and set a “hold” rating for the company in a research note on Friday, August 8th. Finally, Barrington Research decreased their price target on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set an “outperform” rating for the company in a research note on Friday, August 8th. Two equities research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $18.64.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.